Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vertex Pharmaceuticals
(NQ:
VRTX
)
481.24
+1.35 (+0.28%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vertex Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
45
46
Next >
Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
August 23, 2024
Via
Benzinga
Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead
August 23, 2024
Vertex Pharmaceuticals has a lot going for it.
Via
The Motley Fool
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,900 Today
August 21, 2024
Via
Benzinga
Biotech Bull Market: 3 Ways To Play It
August 20, 2024
Although we are in the later stages of this bull market a cut in interest rates by the Fed should help biotech as you have seen from the recent rally.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Soviet Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings
August 19, 2024
Renaissance Technologies, the hedge fund founded by legendary mathematician and former NSA code breaker Jim Simons, recently disclosed its latest stock holdings in a 13F filing with the U.S. Securities...
Via
Benzinga
Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
August 09, 2024
Via
Benzinga
Vertex Slumps On Light Second-Quarter Despite Hiked 2024 Outlook
August 01, 2024
The company's sales came in a hair light with losses wider than expected.
Via
Investor's Business Daily
14 Analysts Assess Vertex Pharmaceuticals: What You Need To Know
July 31, 2024
Via
Benzinga
These 2 Incredible Growth Stocks Are Set to Soar This Summer and Beyond
August 18, 2024
It's always a good time to invest cash in quality businesses.
Via
The Motley Fool
3 Fantastic Growth Stocks to Buy in August
August 17, 2024
These stocks should keep up their winning ways.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
August 15, 2024
Via
Benzinga
3 Biotech Stocks to Buy on the Dip: August 2024
August 15, 2024
These are three of the best biotech stocks to buy on the dip due to their strong fundamentals and market positioning.
Via
InvestorPlace
Prediction: These 4 Future Technologies Will Be Millionaire-Makers -- and Here Are the Top Stocks to Buy Now to Profit From Them
August 15, 2024
These technologies could be game-changers. And they could make forward-thinking investors a lot of money.
Via
The Motley Fool
2 Biotech Stocks to Buy Hand Over Fist in August
August 12, 2024
Both of these biotechs are highly innovative companies.
Via
The Motley Fool
The 3 Best Biotech Stocks to Buy in August 2024
August 08, 2024
These biotech stocks are leading the way with groundbreaking therapies and robust fundamentals offering superb upside ahead.
Via
InvestorPlace
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
August 06, 2024
Shares of the rare disease drugmaker are already up more than 40% over the past year.
Via
The Motley Fool
Prediction: These Could Be the Best-Performing Growth Stocks Through 2030
August 05, 2024
Great companies are found in every type of market landscape.
Via
The Motley Fool
3 Biotech Stocks on Track for 50% Returns (or More) by 2028
August 04, 2024
Investors should consider snapping up these high potential biotech stocks that could return 50% or more by 2028!
Via
InvestorPlace
Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker
August 04, 2024
The biotech recently became a commercial-stage company.
Via
The Motley Fool
3 Unstoppable Stocks to Buy in August
August 03, 2024
It's not hard to envision how all three of these stocks can deliver exceptional growth.
Via
The Motley Fool
Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now
August 03, 2024
These two healthcare companies have far more upside potential than Johnson & Johnson.
Via
The Motley Fool
3 Biotech Stocks That Could Have Investors Grinning Soon
August 02, 2024
Biotech stocks are a high risk, high reward investment and these three biotechs offer significant upside potential.
Via
InvestorPlace
Magnificent 7 Lose Over $300B As Volatility Index Surges, Traders Question Fed's Timing: What's Driving Markets Friday?
August 02, 2024
Wall Street is experiencing a sharp decline on the last trading day of the week, with all indices in the red at noon in New York, as a cooler-than-expected July jobs report rattled risk sentiment and...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Vertex Pharmaceuticals Lifts Annual Guidance, Positive Growth For Its Cystic Fibrosis Franchise And Pain Management Pipeline
August 02, 2024
Vertex Pharmaceuticals reported Q2 revenues of $2.65B, near the $2.66B estimate, with an adjusted EPS loss of $(12.83), missing the $4.14 consensus. The analyst expects strong growth in the pain...
Via
Benzinga
Should Investors Worry About Vertex Pharmaceuticals $3.6 Billion Q2 Loss? Not Even for a Second.
August 02, 2024
Vertex's first loss in years is a big nothingburger.
Via
The Motley Fool
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript
August 01, 2024
VRTX earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever
August 01, 2024
These businesses are looking like increasingly attractive buys.
Via
The Motley Fool
The Top 3 Biotech Stocks to Buy Now Summer 2024
July 31, 2024
These biotech stocks are well-positioned to generate high returns for investors due to their significant growth prospects.
Via
InvestorPlace
US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday?
August 01, 2024
Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively impacted investor risk sentiment, just a day after the Federal Open Market...
Via
Benzinga
Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November
August 01, 2024
After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. The major index futures point to a higher opening, although suggesting a...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
45
46
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.